Cell & Gene Therapy Manufacturing & Commercialization US Post Event Report

In September 2021, Cell and Gene Therapy Manufacturing & Commercialization US returned for the first time as a hybrid conference.

Co-located with BioProcess International, the event spanned across seven days, welcoming audiences in Boston and online, with tracks exploring:

• Cell Therapy
• Gene Edited Ex Vivo Cell Therapy
• In Vivo Gene Therapy
• Partnering & Collaborations
• Tissue Engineering

In this post-event report in association with Avantor, we gather a collection of highlights from the week, including top presentations, a key panel discussion, poster and a spotlight session to watch on demand.

Click the image below or here to explore the report, or download a PDF version using the 'Download Now' link at the top of the page.